Medication info

Ezetimibe/Simvastatin Tablets 10/10

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Celix Co., Ltd.
Appearance
White to pale yellow, biconvex, rectangular tablet
Packaging
- - 30 tablets/PPT [10 tablets/Alu-Alu×3]
Approval status
Expired

MFDS item code 201903818 · Approved 2019.06.11

This product's status changed to Expired on 2024.06.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients receiving this medicine before and during treatment must follow a standard cholesterol-lowering diet. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Use in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see Precautions for Use, 5. General Precautions). Use in older adults No dose adjustment is necessary in older adults. Concomitant use with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Celix Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used as an adjunct to dietary therapy to reduce elevated total cholesterol, LDL-cholesterol, ApoB, and triglycerides, and to increase HDL-cholesterol in patients with primary hypercholesterolemia and mixed hyperlipidemia. It can also be administered to patients with homozygous familial hypercholesterolemia when other treatments are insufficient or additional therapy is needed. This drug should be used alongside a diet restricting saturated fats and cholesterol, and when there is inadequate response to dietary and non-pharmacological measures. Prior to treatment, other causes of dyslipidemia should be identified and treated if necessary, and regular lipid tests should be conducted to monitor treatment effectiveness. This medication contributes to reducing the risk of atherosclerotic vascular disease associated with hypercholesterolemia. Therefore, it is used to effectively improve total cholesterol and LDL-cholesterol levels.

How to take

Adult dose

Patients receiving this medicine before and during treatment must follow a standard cholesterol-lowering diet. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Use in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see Precautions for Use, 5. General Precautions). Use in older adults No dose adjustment is necessary in older adults. Concomitant use with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication may cause muscle-related side effects such as myopathy or rhabdomyolysis. The risk of these side effects increases as the dosage of the drug rises, making caution particularly necessary when taking high doses. If symptoms such as muscle pain, muscle weakness, or unexplained muscular pain occur, inform your doctor immediately. Additionally, this drug may affect liver function; therefore, it should not be administered to patients with liver disease or elevated liver enzyme levels. Pregnant or nursing women should not take this medication, and women of childbearing age should consult a physician before use. This drug may interact with certain medications to increase the risk of myopathy, so inform your healthcare provider of any other medications you are taking. Caution is needed especially when used in combination with strong CYP3A4 inhibitors, fibrates, certain antibiotics, and anticoagulants. Elderly patients and those with hypothyroidism or renal impairment should be carefully observed while taking this medication. Regular blood tests are recommended to monitor liver function and muscle enzyme levels during treatment. Additionally, if a new medication is started while on this drug, inform your healthcare provider that you are currently taking it. In case of overdose, there is no specific antidote available, so immediate medical attention should be sought. This medication has not been adequately studied for safety and efficacy in children and adolescents, thus should be used cautiously and according to a doctor's instructions if necessary.

Side effects

  • Headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
  • abdominal pain
  • viral infection
  • pharyngitis
Show 97 more
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • myopathy
  • rhabdomyolysis
  • immune-mediated necrotizing myopathy
  • dysgeusia
  • ophthalmoplegia
  • facial weakness
  • tremor
  • dizziness
  • paresthesia
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • rheumatoid polymyalgia
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • arthralgia
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • erythema multiforme
  • pancreatitis
  • hepatitis
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • anorexia
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • eye muscle paralysis
  • anemia
  • elevated aminotransferase
  • elevated ALP
  • elevated ɤ-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function test
  • increased HbA1c
  • increased fasting blood glucose
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • dyspepsia
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This ensures that the effectiveness of the medication is preserved and prevents deterioration.

Appearance and packaging

Appearance

White to pale yellow, biconvex, rectangular tablet

Package unit

- - 30 tablets/PPT [10 tablets/Alu-Alu×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.